Is TSC2 p.Ser1132= (c.3396G>T) pathogenic?

TSC2 p.Ser1132= (c.3396G>T) is classified Likely benign in TSC2 (ClinVar, Multiple submitters, 3 submitters; last evaluated 2025-12-15). No allele count reported in gnomAD v4.1 (AN 1,586,602); Associated with hereditary neoplastic syndrome.

What condition is associated with TSC2 p.Ser1132= (c.3396G>T)?

TSC2 p.Ser1132= (c.3396G>T) is associated with hereditary neoplastic syndrome, tuberous sclerosis 2 (ClinVar).

How common is TSC2 p.Ser1132= (c.3396G>T) in the general population?

TSC2 p.Ser1132= (c.3396G>T) is no allele count reported in gnomAD v4.1 (AN 1,586,602) (gnomAD).

TSC2 p.Ser1132=

c.3396G>T · rs373004429 · VCV232786

Likely benign Multiple submitters

Classification

Likely benign

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 3 submitters

gnomAD v4.1

Not reported

no allele count reported in gnomAD v4.1 (AN 1,586,602)

Conditions

hereditary neoplastic syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	<0.2	no splice effect predicted · four deltas, not one · how we know
Constraint at this position
Conservation	phyloP -11	GERP -3.9
Overall
CADD	0.019	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

No allele count reported in gnomAD v4.1 (AN 1,586,602). This is missing data, not an absence: the variant may or may not be present in gnomAD. Rarity (ACMG PM2) and BA1/BS1 cannot be assessed for it.

Variant & gene context

Gene: TSC2
Protein: p.Ser1132=
Coding: c.3396G>T
MANE Select: NM_000548
dbSNP: rs373004429
Type: single nucleotide variant
Location: chr16:2079668 (GRCh38)
Gene constraint: LOEUF 0.203 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure: AlphaFold pLDDT 68.81 · 2 PDB
Residue 1132: a modified residue (phosphoserine); the 'disordered' region

Full TSC2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: tuberous sclerosis 2

Similar variants

TSC2 p.Ser1132Leu Conflicting classifications of pathogenicity ★ ⚠ same residue
TSC2 p.Ser1132Trp Uncertain significance ★ ⚠ same residue
TSC2 p.Ser1132Ter Pathogenic ★ same residue
TSC2 c.1257+1G>A Pathogenic ★★ same condition
TSC2 c.1258-2A>G Pathogenic ★★ same condition
TSC2 c.1361+1G>A Pathogenic/Likely pathogenic ★★ same condition
TSC2 c.1361+1G>T Pathogenic/Likely pathogenic ★★ same condition
TSC2 c.1362-1G>A Pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tsc2-p-ser1132 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown